speb/financial-data huggingface dataset:
Financial ratios for RRX — quarterly report dated 2025-03-31
Total revenue: 1418100000
Gross profit: 527600000
Operating income: 159700000
Net income: 57500000
Capital expenditures: 6500000
Operating cash flow: 102300000
Depreciation & amortization: 125500000
Net tangible assets: -3706900000
Owner earnings: 176500000
Return on net tangible assets (%): -4.761390919636354
Capex to operating income (%): 4.0701314965560424
Buffett classification: The Great
Stock price: 112.62
P/E ratio: 32.59593613591304
Shares outstanding: 66569573
Book value: 6430400000
P/B ratio: 1.1658785318580491
Market cap (USD): 7497065311.26
Debt to equity: 0.8482053993530729
Current ratio: 2.2598489822718317
Quick ratio: 1.2101116217990808
Effective tax rate (%): 21.232876712328768
Interest coverage ratio: 1.770509977827051
COGS to revenue (%): 62.79528947182851
Free cash flow (dilution-adjusted): 76000000
Buyback yield (%): 0
Retained earnings: 2077900000
Inventory turnover: 0.6962470680218921
Receivables turnover: 1.6642412862340101
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2463028430064227
FCF margin (%): 5.359283548409844
Rule of 40 score: 5.359283548409844
Financial ratios for RRX — quarterly report dated 2025-06-30
Total revenue: 1496100000
Gross profit: 564700000
Operating income: 182300000
Net income: 79600000
Capital expenditures: 25700000
Operating cash flow: 523200000
Depreciation & amortization: 122300000
Net tangible assets: -3500200000
Owner earnings: 176200000
Return on net tangible assets (%): -5.033998057253871
Capex to operating income (%): 14.097641250685683
Buffett classification: The Great
Stock price: 143.74
P/E ratio: 69.79365735244347
Shares outstanding: 66569573
Book value: 6707900000
P/B ratio: 1.4264837613888102
Market cap (USD): 9568710423.02
Debt to equity: 0.7459562605286304
Current ratio: 1.9988889770653122
Quick ratio: 0.9288945321799857
Effective tax rate (%): 21.34387351778656
Interest coverage ratio: 2.1371629542790154
COGS to revenue (%): 62.255196845130676
Free cash flow (dilution-adjusted): 482700000
Buyback yield (%): 0
Retained earnings: 2133700000
Inventory turnover: 0.6907958169546837
Receivables turnover: 2.7206764866339332
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4419502317561261
FCF margin (%): 32.26388610387006
Revenue growth (%): 5.5003173259995775
Rule of 40 score: 37.76420342986963
Financial ratios for RRX — quarterly report dated 2025-09-30
Total revenue: 1497000000
Gross profit: 554200000
Operating income: 174400000
Net income: 80000000
Capital expenditures: 22900000
Operating cash flow: 197500000
Depreciation & amortization: 129200000
Net tangible assets: -3344300000
Owner earnings: 186300000
Return on net tangible assets (%): -5.570672487516072
Capex to operating income (%): 13.130733944954128
Buffett classification: The Great
Stock price: 142.58
P/E ratio: 43.71943674960848
Shares outstanding: 66569573
Book value: 6772300000
P/B ratio: 1.4015164299189347
Market cap (USD): 9491489718.34
Debt to equity: 0.7282311770004282
Current ratio: 2.048562855337966
Quick ratio: 0.9696778269109286
Effective tax rate (%): 12.948857453754082
Interest coverage ratio: 2.004597701149425
COGS to revenue (%): 62.97929191716767
Free cash flow (dilution-adjusted): 164700000
Buyback yield (%): 0
Retained earnings: 2190000000
Inventory turnover: 0.6900387908951182
Receivables turnover: 2.9468503937007875
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.3832816453437184
FCF margin (%): 11.002004008016032
Revenue growth (%): 0.060156406657309
Rule of 40 score: 11.062160414673341
Financial ratios for RRX — quarterly report dated 2025-12-31
Total revenue: 1523300000
Gross profit: 571300000
Operating income: 169000000
Net income: 63800000
Capital expenditures: 18900000
Operating cash flow: 167800000
Depreciation & amortization: 123600000
Net tangible assets: -3185600000
Owner earnings: 168500000
Return on net tangible assets (%): -5.289427423405324
Capex to operating income (%): 11.18343195266272
Buffett classification: The Great
Stock price: 139.82
P/E ratio: 33.135484858882165
Shares outstanding: 66569573
Book value: 6853300000
P/B ratio: 1.3581424564603912
Market cap (USD): 9307757696.859999
Debt to equity: 0.7209957246873769
Current ratio: 2.145297793245274
Quick ratio: 1.0998971763030927
Effective tax rate (%): 26.242774566473987
Interest coverage ratio: 1.9492502883506344
COGS to revenue (%): 62.49589706558131
Free cash flow (dilution-adjusted): 132400000
Buyback yield (%): 0
Retained earnings: 2230300000
Inventory turnover: 0.7202844821063782
Receivables turnover: 2.905951926745517
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.335261166022739
FCF margin (%): 8.691656272566139
Revenue growth (%): 1.7568470273881094
Rule of 40 score: 10.448503299954249
Financial ratios for RRX — annual report dated 2025-12-31
Total revenue: 5934500000
Gross profit: 2217800000
Operating income: 685300000
Net income: 280800000
Capital expenditures: 74000000
Operating cash flow: 990800000
Depreciation & amortization: 500600000
Net tangible assets: -3185600000
Owner earnings: 707400000
Return on net tangible assets (%): -22.206177800100452
Capex to operating income (%): 10.798190573471473
Buffett classification: The Great
Stock price: 139.82
P/E ratio: 33.14728524522792
Shares outstanding: 66569573
Book value: 6853300000
P/B ratio: 1.3581424564603912
Market cap (USD): 9307757696.859999
Debt to equity: 0.7209957246873769
Current ratio: 2.145297793245274
Quick ratio: 1.0998971763030927
Effective tax rate (%): 20.340425531914892
Interest coverage ratio: 1.9624856815578464
COGS to revenue (%): 62.62869660460022
Free cash flow (dilution-adjusted): 855800000
Buyback yield (%): 0
Retained earnings: 2230300000
Inventory turnover: 2.812060225467201
Receivables turnover: 11.321060663868753
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.414523532990432
FCF margin (%): 14.420759962928637
Revenue growth (%): -1.6457290596307468
Rule of 40 score: 12.775030903297889
Financial ratios for SANG — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 17.92
Shares outstanding: 33278790
Market cap (USD): 596355916.8000001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SANG — annual report dated 2022-06-30
Total revenue: 173916279.06976745
Gross profit: 121618604.65116279
Operating income: -4283720.930232558
Net income: -85875968.99224806
Capital expenditures: 1448062.015503876
Operating cash flow: 16323255.813953487
Depreciation & amortization: 30504651.162790697
Net tangible assets: -85605426.35658914
Owner earnings: -56819379.84496123
Buffett classification: The Gruesome
Stock price: 8.4
Shares outstanding: 33278790
Book value: 227758139.53488368
P/B ratio: 1.2273626601045584
Market cap (USD): 279541836
Debt to equity: 0.41732696182540985
Current ratio: 0.7691758283804812
Quick ratio: 0.5469224294059128
Interest coverage ratio: -1.4260645161290324
COGS to revenue (%): 30.070603337612322
R&D to revenue (%): 15.22518185708173
SG&A to revenue (%): 57.16730851519042
Free cash flow (dilution-adjusted): 4668992.2480620155
Buyback yield (%): 0
Retained earnings: -80813953.48837209
Inventory turnover: 3.871456444393435
Receivables turnover: 8.914176732358552
Capitalized R&D asset: 26479069.76744186
ROCI (R&D-adjusted, %): 3.7962952771938325
FCF margin (%): 2.684620596205962
Rule of 40 score: 2.684620596205962
Financial ratios for SANG — annual report dated 2023-06-30
Total revenue: 189872180.4511278
Gross profit: 129918045.11278194
Operating income: -2217293.2330827066
Net income: -21824060.15037594
Capital expenditures: 3019548.872180451
Operating cash flow: 19915037.59398496
Depreciation & amortization: 33942857.14285714
Net tangible assets: -64205263.15789473
Owner earnings: 9099248.120300751
Buffett classification: The Gruesome
Stock price: 3.7
Shares outstanding: 33278790
Book value: 200086466.1654135
P/B ratio: 0.6153915622569192
Market cap (USD): 123131523
Debt to equity: 0.43273021062322686
Current ratio: 0.9752930795411572
Quick ratio: 0.6921404260683222
Interest coverage ratio: -0.4357913403280626
COGS to revenue (%): 31.57605037025304
R&D to revenue (%): 14.837841048588288
SG&A to revenue (%): 41.31707123906071
Free cash flow (dilution-adjusted): 9113533.834586464
Buyback yield (%): 0.36943197563235913
Retained earnings: -100207518.79699248
Inventory turnover: 4.437340011129661
Receivables turnover: 9.307459826035677
Capitalized R&D asset: 45913909.075013116
ROCI (R&D-adjusted, %): 2.3357845942624853
Rosenberg metric: 0.3134339889773613
FCF margin (%): 4.799825763275649
Revenue growth (%): 9.174472606419757
Rule of 40 score: 13.974298369695406
Financial ratios for SANG — annual report dated 2024-06-30
Total revenue: 180499270.07299268
Gross profit: 126146715.32846715
Operating income: -775182.4817518247
Net income: -6320437.956204379
Capital expenditures: 3014598.5401459853
Operating cash flow: 32296350.3649635
Depreciation & amortization: 32959124.08759124
Net tangible assets: -43583941.60583942
Owner earnings: 23624087.591240875
Buffett classification: The Gruesome
Stock price: 5.01
Shares outstanding: 33278790
Book value: 189583941.60583937
P/B ratio: 0.8794349167327612
Market cap (USD): 166726737.9
Debt to equity: 0.3430832017864706
Current ratio: 0.9501697058432053
Quick ratio: 0.7044622654066286
Interest coverage ratio: -0.15936374549819926
COGS to revenue (%): 30.11234046683166
R&D to revenue (%): 15.990925413694375
SG&A to revenue (%): 40.85626243509488
Free cash flow (dilution-adjusted): 22154014.598540146
Buyback yield (%): 0
Retained earnings: -103602189.7810219
Inventory turnover: 5.042185807150596
Receivables turnover: 11.493028443948688
Capitalized R&D asset: 56477461.33454499
ROCI (R&D-adjusted, %): 0.08189518806181258
Rosenberg metric: -0.1338635872201409
FCF margin (%): 12.273741932353085
Revenue growth (%): -4.936431633041502
Rule of 40 score: 7.337310299311583
Financial ratios for SANG — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.61
Shares outstanding: 33278790
Market cap (USD): 186694011.9
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SANG — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.14
Shares outstanding: 33278790
Market cap (USD): 237610560.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SANG — quarterly report dated 2025-03-31
Total revenue: 40606293.70629371
Gross profit: 27999300.6993007
Operating income: -395804.1958041958
Net income: -998601.3986013987
Capital expenditures: 434965.034965035
Operating cash flow: 7426573.426573426
Depreciation & amortization: 7965734.2657342665
Net tangible assets: -26989510.48951049
Owner earnings: 6532167.832167833
Buffett classification: The Gruesome
Stock price: 4.45
Shares outstanding: 33278790
Book value: 178501398.60139862
P/B ratio: 0.8296328020974939
Market cap (USD): 148090615.5
Debt to equity: 0.24406774348989452
Current ratio: 0.8677948460268466
Quick ratio: 0.6934355035532267
Interest coverage ratio: -0.6002120890774125
COGS to revenue (%): 31.046894105085503
R&D to revenue (%): 18.024006750822323
SG&A to revenue (%): 37.78393924259906
Free cash flow (dilution-adjusted): 5481118.881118881
Buyback yield (%): 0.03683248554359243
Retained earnings: -102904895.10489511
Inventory turnover: 1.8554960889254837
Receivables turnover: 4.953676846954445
Capitalized R&D asset: 7318881.118881119
ROCI (R&D-adjusted, %): 2.0277671473046217
FCF margin (%): 13.498200354762599
Rule of 40 score: 13.498200354762599
Financial ratios for SANG — quarterly report dated 2025-06-30
Total revenue: 43329927.00729927
Gross profit: 29227007.29927007
Operating income: 713868.613138686
Net income: 152554.74452554743
Capital expenditures: 600000
Operating cash flow: 5201459.854014598
Depreciation & amortization: 7947445.255474452
Net tangible assets: -23508759.12408759
Owner earnings: 7499999.999999999
Return on net tangible assets (%): -31.903002452882912
Capex to operating income (%): 84.04907975460124
Buffett classification: The Gruesome
Stock price: 6.05
P/E ratio: 329.9416876973685
Shares outstanding: 33278790
Book value: 185543795.62043792
P/B ratio: 1.0851167446841992
Market cap (USD): 201336679.5
Debt to equity: 0.22072818112079312
Current ratio: 0.861468186595521
Quick ratio: 0.6951855445064273
Interest coverage ratio: 1.211895910780669
COGS to revenue (%): 32.54775782487113
R&D to revenue (%): 16.876116033826356
SG&A to revenue (%): 35.1622249924194
Free cash flow (dilution-adjusted): 3043065.693430657
Buyback yield (%): 0.9995241622747073
Retained earnings: -107259124.08759123
Inventory turnover: 2.3484866901665247
Receivables turnover: 3.4881889763779528
Capitalized R&D asset: 12216059.108774439
ROCI (R&D-adjusted, %): 1.3748594219077006
Rosenberg metric: 0.16774512115002885
FCF margin (%): 7.0230113540648915
Revenue growth (%): 6.707416640153524
Rule of 40 score: 13.730427994218417
Financial ratios for SANG — annual report dated 2025-06-30
Total revenue: 172767883.21167883
Gross profit: 118064963.50364962
Operating income: -927737.2262773722
Net income: -3656934.306569343
Capital expenditures: 1745255.4744525547
Operating cash flow: 30500729.927007295
Depreciation & amortization: 32878832.11678832
Net tangible assets: -23508759.12408759
Owner earnings: 27476642.335766423
Buffett classification: The Gruesome
Stock price: 6.05
Shares outstanding: 33278790
Book value: 185543795.62043792
P/B ratio: 1.0851167446841992
Market cap (USD): 201336679.5
Debt to equity: 0.22072818112079312
Current ratio: 0.861468186595521
Quick ratio: 0.6951855445064273
Interest coverage ratio: -0.29877762106252936
COGS to revenue (%): 31.662667094789853
R&D to revenue (%): 17.80753046152806
SG&A to revenue (%): 37.22263532354283
Free cash flow (dilution-adjusted): 21926277.372262772
Buyback yield (%): 1.0278023213815
Retained earnings: -107259124.08759123
Inventory turnover: 9.109395891576517
Receivables turnover: 13.908332353978142
Capitalized R&D asset: 59401308.54508534
ROCI (R&D-adjusted, %): 0.20655218107529885
Rosenberg metric: -0.279998988442961
FCF margin (%): 12.691176719111757
Revenue growth (%): -4.2833341421199815
Rule of 40 score: 8.407842576991776
Financial ratios for SANG — quarterly report dated 2025-09-30
Total revenue: 36559712.23021583
Gross profit: 26478417.266187053
Operating income: -1187769.784172662
Net income: -1681294.964028777
Capital expenditures: 3064028.7769784173
Operating cash flow: 3552517.985611511
Depreciation & amortization: 7880575.539568346
Net tangible assets: -19276258.992805757
Owner earnings: 3135251.798561151
Buffett classification: The Gruesome
Stock price: 4.91
Shares outstanding: 33278790
Book value: 180891366.90647483
P/B ratio: 0.9032982706382066
Market cap (USD): 163398858.9
Debt to equity: 0.20122176750623413
Current ratio: 0.8706678626763434
Quick ratio: 0.7167495718828998
Interest coverage ratio: -2.089873417721519
COGS to revenue (%): 27.57487504427565
R&D to revenue (%): 22.261797001062614
SG&A to revenue (%): 37.331260576960915
Free cash flow (dilution-adjusted): 1943165.4676258995
Buyback yield (%): 0.01937264217883275
Retained earnings: -107397122.30215828
Inventory turnover: 1.856026490066225
Receivables turnover: 3.4334166610364165
Capitalized R&D asset: 15453393.558707219
ROCI (R&D-adjusted, %): -0.28718903670632984
Rosenberg metric: -0.3758802500822255
FCF margin (%): 5.315045849895706
Revenue growth (%): -15.624800789401142
Rule of 40 score: -10.309754939505435
Financial ratios for SANG — quarterly report dated 2025-12-31
Total revenue: 37554744.525547445
Gross profit: 27916788.321167883
Operating income: -1253284.6715328465
Net income: -1456934.306569343
Capital expenditures: 1527737.226277372
Operating cash flow: 7394890.510948905
Depreciation & amortization: 7879562.04379562
Net tangible assets: -14752554.744525546
Owner earnings: 4894890.510948906
Buffett classification: The Gruesome
Stock price: 5.07
Shares outstanding: 33278790
Book value: 182511678.83211678
P/B ratio: 0.924452979555353
Market cap (USD): 168723465.3
Debt to equity: 0.1807983490707524
Current ratio: 0.8713593292869307
Quick ratio: 0.7129164665298457
Interest coverage ratio: -2.9501718213058417
COGS to revenue (%): 25.66375121477162
R&D to revenue (%): 20.237123420796888
SG&A to revenue (%): 41.56268221574344
Free cash flow (dilution-adjusted): 5261313.868613138
Buyback yield (%): 0.42569548574965266
Retained earnings: -110421897.81021897
Inventory turnover: 1.8194846355243213
Receivables turnover: 4.6247191011235955
Capitalized R&D asset: 15466123.667489367
ROCI (R&D-adjusted, %): -0.6089309661869144
Rosenberg metric: 0.17672905210141895
FCF margin (%): 14.009718172983476
Revenue growth (%): 2.721663368316228
Rule of 40 score: 16.731381541299704
Financial ratios for SJS.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.365554529869445
Shares outstanding: 32005154
Market cap (USD): 171725399.0238692
Buyback yield (%): 0
Retained earnings: 42781221.15257814
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SJS.NS — annual report dated 2023-03-31
Total revenue: 52621559.07429964
Gross profit: 25213885.505481124
Operating income: 10203897.685749087
Net income: 8191595.615103533
Capital expenditures: 3725091.3520097444
Operating cash flow: 10597320.341047503
Depreciation & amortization: 2838124.2387332525
Net tangible assets: 48165529.84165652
Owner earnings: 7304628.501827042
Return on net tangible assets (%): 15.165676627747898
Capex to operating income (%): 36.506553345906845
Buffett classification: The Good
Stock price: 4.797076735688186
P/E ratio: 18.7425242760323
Shares outstanding: 32005154
Book value: 52331181.4859927
P/B ratio: 2.9338374429137017
Market cap (USD): 153531179.67551768
Debt to equity: 0.07095724550145587
Current ratio: 3.4256376319472324
Quick ratio: 2.900408995736464
Effective tax rate (%): 26.233410112975758
Interest coverage ratio: 36.250108178277806
COGS to revenue (%): 52.08449550139692
SG&A to revenue (%): 3.2389479263835486
Free cash flow (dilution-adjusted): 6540803.897685749
Buyback yield (%): 0
Retained earnings: 47705602.92326432
Inventory turnover: 4.647767174784153
Receivables turnover: 4.79886921555995
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.7859774543155
FCF margin (%): 12.429893778803443
Rule of 40 score: 12.429893778803443
Financial ratios for SJS.NS — annual report dated 2024-03-31
Total revenue: 72921333.4932246
Gross profit: 32484710.396930087
Operating income: 13814606.067873845
Net income: 10237558.460247032
Capital expenditures: 3549346.444417796
Operating cash flow: 12926250.149898069
Depreciation & amortization: 4645880.801055282
Net tangible assets: 34833313.34692409
Owner earnings: 11334092.816884518
Return on net tangible assets (%): 32.53808417247612
Capex to operating income (%): 25.692708333333336
Buffett classification: The Good
Stock price: 7.284668905950096
P/E ratio: 22.7736868198864
Shares outstanding: 32005154
Book value: 67346204.580885
P/B ratio: 3.461916697828565
Market cap (USD): 233146950.17394435
Debt to equity: 0.14995370370370373
Current ratio: 2.032964438951914
Quick ratio: 1.5333393504311483
Effective tax rate (%): 24.215039636392692
Interest coverage ratio: 13.51953996009858
COGS to revenue (%): 55.45239117171607
SG&A to revenue (%): 3.4498126102836584
Free cash flow (dilution-adjusted): 8741815.565415516
Buyback yield (%): 0
Retained earnings: 57138625.73450054
Inventory turnover: 4.685755179745147
Receivables turnover: 3.7669253975431927
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.844059647486883
FCF margin (%): 11.988008373746691
Revenue growth (%): 38.57691557610913
Rule of 40 score: 50.564923949855825
Financial ratios for SJS.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 41644529.38365982
Buffett classification: The Gruesome
Stock price: 11.924271380793119
Shares outstanding: 32005154
Book value: 73405757.28619206
P/B ratio: 5.199021929467434
Market cap (USD): 381638141.8800764
Debt to equity: 0.039944479971621656
Current ratio: 2.4553088040090083
Quick ratio: 1.9286491968560306
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SJS.NS — quarterly report dated 2024-12-31
Total revenue: 20813847.767805103
Gross profit: 11158526.634805921
Operating income: 3948945.098496328
Net income: 3230096.747872712
Capital expenditures: 0
Depreciation & amortization: 1328826.2035202237
Owner earnings: 4558922.951392936
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 13.40319384543653
P/E ratio: 33.201117226408286
Shares outstanding: 32005154
Market cap (USD): 428971283.11504835
Effective tax rate (%): 22.720174019744547
Interest coverage ratio: 35.84973544973545
COGS to revenue (%): 46.388929335468916
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SJS.NS — quarterly report dated 2025-03-31
Total revenue: 23440729.483282674
Gross profit: 12484802.431610942
Operating income: 4617138.180967968
Net income: 3943652.0925882626
Capital expenditures: 0
Depreciation & amortization: 1345452.419920505
Net tangible assets: 50192424.59667991
Owner earnings: 5289104.512508768
Return on net tangible assets (%): 10.537654944962805
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 10.504259540203059
P/E ratio: 21.312126193383513
Shares outstanding: 32005154
Book value: 80575052.6069675
P/B ratio: 4.172388765044343
Market cap (USD): 336190444.2401681
Debt to equity: 0.05392323997916543
Current ratio: 2.802370703365211
Quick ratio: 2.311329756780254
Effective tax rate (%): 16.909283479888668
Interest coverage ratio: 57.15629522431259
COGS to revenue (%): 46.73884854771784
Buyback yield (%): 0
Retained earnings: 68749590.83469722
Inventory turnover: 1.3490089389817335
Receivables turnover: 1.1613516049439923
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.390609325160408
Revenue growth (%): 12.620836592938073
Rule of 40 score: 12.620836592938073
Financial ratios for SJS.NS — annual report dated 2025-03-31
Total revenue: 88663783.02548514
Gross profit: 40190787.935468785
Operating income: 17806640.168342296
Net income: 13891980.360065466
Capital expenditures: 4309095.16015899
Operating cash flow: 19055997.194295064
Depreciation & amortization: 5225976.151508066
Net tangible assets: 50192424.59667991
Owner earnings: 14808861.35141454
Return on net tangible assets (%): 29.50417611902754
Capex to operating income (%): 24.199372365708584
Buffett classification: The Great
Stock price: 10.504259540203059
P/E ratio: 24.20032533349938
Shares outstanding: 32005154
Book value: 80575052.6069675
P/B ratio: 4.172388765044343
Market cap (USD): 336190444.2401681
Debt to equity: 0.05392323997916543
Current ratio: 2.802370703365211
Quick ratio: 2.311329756780254
Effective tax rate (%): 22.262926522922335
Interest coverage ratio: 27.00195000886368
COGS to revenue (%): 54.67056946587029
SG&A to revenue (%): 2.771910393839906
Free cash flow (dilution-adjusted): 13544540.56581716
Buyback yield (%): 0
Retained earnings: 68749590.83469722
Inventory turnover: 5.968504843747751
Receivables turnover: 4.39277398728092
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.789639984549517
FCF margin (%): 15.276294450377756
Revenue growth (%): 21.58826337661972
Rule of 40 score: 36.864557826997476
Financial ratios for SJS.NS — quarterly report dated 2025-06-30
Total revenue: 24532880.879943836
Gross profit: 13621109.290896326
Operating income: 5154809.267493565
Net income: 4050549.964895858
Capital expenditures: 0
Depreciation & amortization: 1387783.7584835012
Owner earnings: 5438333.723379359
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 14.96009829159841
P/E ratio: 42.65747535598705
Shares outstanding: 32005154
Market cap (USD): 478800249.67774403
Effective tax rate (%): 24.644621982280075
Interest coverage ratio: 47.52211434735707
COGS to revenue (%): 44.47815013021206
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 4.659203961378662
Rule of 40 score: 4.659203961378662
Financial ratios for SJS.NS — quarterly report dated 2025-12-31
Total revenue: 27128327.94920352
Gross profit: 15968809.179013034
Operating income: 6349114.403475549
Net income: 5017154.951542832
Capital expenditures: 0
Depreciation & amortization: 1602428.428205414
Owner earnings: 6619583.379748246
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 18.900969143366382
P/E ratio: 37.24595330179138
Shares outstanding: 32005154
Market cap (USD): 604928428.1826891
Effective tax rate (%): 25.251435589338467
Interest coverage ratio: 56.995999999999995
COGS to revenue (%): 41.136036069329975
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 10.579463055973662
Rule of 40 score: 10.579463055973662
Financial ratios for SKWD — annual report dated 2023-12-31
Total revenue: 895403000
Net income: 85984000
Capital expenditures: 3108000
Operating cash flow: 338187000
Depreciation & amortization: 3891000
Net tangible assets: 572596000
Owner earnings: 86767000
Return on net tangible assets (%): 15.153266875772797
Buffett classification: The Gruesome
Stock price: 33.88
P/E ratio: 15.975053989114254
Shares outstanding: 40543065
Book value: 661031000
P/B ratio: 2.0779646373619394
Market cap (USD): 1373599042.2
Debt to equity: 0.19468073358132978
Effective tax rate (%): 21.905142504223356
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 326504000
Buyback yield (%): 0
Retained earnings: -21708000
Receivables turnover: 1.1545110750945435
Capitalized R&D asset: 0
FCF margin (%): 36.46447465554616
Revenue growth (%): 40.697040406659276
Rule of 40 score: 77.16151506220544
Financial ratios for SKWD — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 40.73
Shares outstanding: 40543065
Market cap (USD): 1651319037.4499998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SKWD — quarterly report dated 2024-12-31
Capital expenditures: 1076000
Buffett classification: The Gruesome
Stock price: 50.54
Shares outstanding: 40543065
Market cap (USD): 2049046505.1
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SKWD — annual report dated 2024-12-31
Total revenue: 1147676000
Net income: 118828000
Capital expenditures: 4224000
Operating cash flow: 305115000
Depreciation & amortization: 3358000
Net tangible assets: 706651000
Owner earnings: 117962000
Return on net tangible assets (%): 16.693105932065475
Buffett classification: The Gruesome
Stock price: 50.54
P/E ratio: 17.243802008785806
Shares outstanding: 40543065
Book value: 793999000
P/B ratio: 2.5806663548694644
Market cap (USD): 2049046505.1
Debt to equity: 0.15054930799660957
Effective tax rate (%): 22.20192616162211
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 291496000
Buyback yield (%): 0
Retained earnings: 97120000
Receivables turnover: 0.9730050520679228
Capitalized R&D asset: 0
FCF margin (%): 25.398805934776014
Revenue growth (%): 28.17424109590877
Rule of 40 score: 53.57304703068478
Financial ratios for SKWD — quarterly report dated 2025-03-31
Total revenue: 330515000
Net income: 42058000
Capital expenditures: 202000
Operating cash flow: 96760000
Depreciation & amortization: 337000
Net tangible assets: 763632000
Owner earnings: 42193000
Return on net tangible assets (%): 5.525305382697425
Buffett classification: The Gruesome
Stock price: 52.92
P/E ratio: 12.753453562936897
Shares outstanding: 40543065
Book value: 850721000
P/B ratio: 2.522024259187207
Market cap (USD): 2145538999.8
Debt to equity: 0.14052198076690242
Effective tax rate (%): 18.230776708466998
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 96558000
Buyback yield (%): 0
Retained earnings: 139178000
Receivables turnover: 0.25029306814326563
Capitalized R&D asset: 0
FCF margin (%): 29.21440781810205
Rule of 40 score: 29.21440781810205
Financial ratios for SKWD — quarterly report dated 2025-06-30
Total revenue: 320801000
Net income: 38839000
Capital expenditures: 1085000
Operating cash flow: 88180000
Depreciation & amortization: 372000
Net tangible assets: 811120000
Owner earnings: 38126000
Return on net tangible assets (%): 4.700414242035704
Buffett classification: The Gruesome
Stock price: 57.79
P/E ratio: 28.962553943285908
Shares outstanding: 40543065
Book value: 899915000
P/B ratio: 2.603561143385764
Market cap (USD): 2342983726.35
Debt to equity: 0.13284921353683404
Effective tax rate (%): 22.00220905713425
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 85095000
Buyback yield (%): 0
Retained earnings: 178017000
Receivables turnover: 0.2222025971579213
Capitalized R&D asset: 0
FCF margin (%): 26.525790131576898
Revenue growth (%): -2.939049664916872
Rule of 40 score: 23.586740466660025
Financial ratios for SKWD — quarterly report dated 2025-09-30
Total revenue: 382181000
Net income: 45901000
Capital expenditures: 2460000
Operating cash flow: 171368000
Depreciation & amortization: 455000
Net tangible assets: 873006000
Owner earnings: 43896000
Return on net tangible assets (%): 5.028144136466416
Buffett classification: The Gruesome
Stock price: 47.56
P/E ratio: 15.207086637013202
Shares outstanding: 40543065
Book value: 961423000
P/B ratio: 2.005598130479508
Market cap (USD): 1928228171.4
Debt to equity: 0.12435837295342425
Effective tax rate (%): 24.18947264108874
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 168908000
Buyback yield (%): 0
Retained earnings: 223918000
Receivables turnover: 0.2536789255479724
Capitalized R&D asset: 0
FCF margin (%): 44.19581297866718
Revenue growth (%): 19.1333568162194
Rule of 40 score: 63.32916979488658
Financial ratios for SKWD — quarterly report dated 2025-12-31
Total revenue: 385727000
Net income: 43230000
Capital expenditures: 1707000
Operating cash flow: 51768000
Depreciation & amortization: 472000
Net tangible assets: 921525000
Owner earnings: 41995000
Return on net tangible assets (%): 4.557119991318738
Buffett classification: The Gruesome
Stock price: 51.11
P/E ratio: 12.187145953313571
Shares outstanding: 40543065
Book value: 1009565000
P/B ratio: 2.052523663310436
Market cap (USD): 2072156052.15
Debt to equity: 0.11884326417813613
Effective tax rate (%): 20.892272219883985
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 50061000
Buyback yield (%): 0
Retained earnings: 267148000
Receivables turnover: 0.2317935793406274
Capitalized R&D asset: 0
FCF margin (%): 12.978349972908301
Revenue growth (%): 0.9278326238091377
Rule of 40 score: 13.90618259671744
Financial ratios for SKWD — annual report dated 2025-12-31
Total revenue: 1419224000
Net income: 170028000
Capital expenditures: 5454000
Operating cash flow: 408076000
Depreciation & amortization: 3535000
Net tangible assets: 921525000
Owner earnings: 168109000
Return on net tangible assets (%): 18.242478500311982
Buffett classification: The Gruesome
Stock price: 51.11
P/E ratio: 12.187145953313571
Shares outstanding: 40543065
Book value: 1009565000
P/B ratio: 2.052523663310436
Market cap (USD): 2072156052.15
Debt to equity: 0.11884326417813613
Effective tax rate (%): 21.43754851587624
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 388662000
Buyback yield (%): 0
Retained earnings: 267148000
Receivables turnover: 0.8528493230863345
Capitalized R&D asset: 0
FCF margin (%): 27.385528993309023
Revenue growth (%): 23.660684722866034
Rule of 40 score: 51.04621371617506
Financial ratios for TELO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.42
Shares outstanding: 68774956
Market cap (USD): 441535217.52
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TELO — annual report dated 2024-12-31
Total revenue: 0
Operating income: -12242174
Net income: -16532716
Capital expenditures: 0
Operating cash flow: -5070428
Net tangible assets: 643037
Owner earnings: -16532716
Return on net tangible assets (%): -2571.0365033427315
Buffett classification: The Gruesome
Stock price: 4.12
Shares outstanding: 68774956
Book value: 643037
P/B ratio: 440.6477678889395
Market cap (USD): 283352818.72
Debt to equity: 0
Current ratio: 1.944298410497997
Quick ratio: 1.944298410497997
Interest coverage ratio: -2.8217253630367067
Free cash flow (dilution-adjusted): -11937704
Buyback yield (%): 0
Retained earnings: -30596858
Capitalized R&D asset: 3565084
ROCI (R&D-adjusted, %): -274.5750577672711
Rule of 40 score: 0
Financial ratios for TELO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.12
Shares outstanding: 68774956
Market cap (USD): 283352818.72
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TELO — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -2187782
Net income: -2179828
Capital expenditures: 0
Operating cash flow: -863132
Net tangible assets: -161106
Owner earnings: -2179828
Buffett classification: The Gruesome
Stock price: 3.23
Shares outstanding: 68774956
Book value: -161106
Market cap (USD): 222143107.88
Debt to equity: 0
Current ratio: 0.7530162779360227
Quick ratio: 0.7530162779360227
Interest coverage ratio: -47560.47826086957
Free cash flow (dilution-adjusted): -2238818
Buyback yield (%): 0
Retained earnings: -32776686
Capitalized R&D asset: 336996
ROCI (R&D-adjusted, %): -1116.1055204957645
Rule of 40 score: 0
Financial ratios for TELO — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -5069910
Net income: -5069890
Capital expenditures: 0
Operating cash flow: -696445
Net tangible assets: 481223
Owner earnings: -5069890
Return on net tangible assets (%): -1053.5427442162988
Buffett classification: The Gruesome
Stock price: 1.25
Shares outstanding: 68774956
Book value: 481223
P/B ratio: 178.64627210253875
Market cap (USD): 85968695
Debt to equity: 0
Current ratio: 2.381284659632364
Quick ratio: 2.381284659632364
Interest coverage ratio: -3777.876304023845
Free cash flow (dilution-adjusted): -5360895
Buyback yield (%): 0
Retained earnings: -37846576
Capitalized R&D asset: 268626.32
ROCI (R&D-adjusted, %): -687.2957711912929
Rule of 40 score: 0
Financial ratios for TELO — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -1146476
Net income: -1102294
Capital expenditures: 0
Operating cash flow: -927264
Net tangible assets: 6979310
Owner earnings: -1102294
Return on net tangible assets (%): -15.79373892261556
Buffett classification: The Gruesome
Stock price: 1.39
Shares outstanding: 68774956
Book value: 6979310
P/B ratio: 13.697226350455846
Market cap (USD): 95597188.83999999
Debt to equity: 0
Current ratio: 17.50708242767977
Quick ratio: 17.50708242767977
Free cash flow (dilution-adjusted): -185406
Buyback yield (%): 0
Retained earnings: -38948870
Capitalized R&D asset: 899435.81
ROCI (R&D-adjusted, %): -9.731722347146858
Rule of 40 score: 0
Financial ratios for TELO — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -2134681
Net income: -2061193
Capital expenditures: 0
Operating cash flow: -1201347
Net tangible assets: 5913370
Owner earnings: -2061193
Return on net tangible assets (%): -34.856486233738124
Buffett classification: The Gruesome
Stock price: 1.33
Shares outstanding: 68774956
Book value: 5913370
P/B ratio: 15.468453940815476
Market cap (USD): 91470691.48
Debt to equity: 0
Current ratio: 5.141041505163548
Quick ratio: 5.141041505163548
Free cash flow (dilution-adjusted): -2033398
Buyback yield (%): 0
Retained earnings: -41010063
Capitalized R&D asset: 1819227.62
ROCI (R&D-adjusted, %): -19.88977584137287
Rule of 40 score: 0
Financial ratios for TELO — annual report dated 2025-12-31
Total revenue: 0
Operating income: -10538849
Net income: -10413205
Capital expenditures: 0
Operating cash flow: -3688188
Net tangible assets: 5913370
Owner earnings: -10413205
Return on net tangible assets (%): -176.09594867224612
Buffett classification: The Gruesome
Stock price: 1.33
Shares outstanding: 68774956
Book value: 5913370
P/B ratio: 15.468453940815476
Market cap (USD): 91470691.48
Debt to equity: 0
Current ratio: 5.141041505163548
Quick ratio: 5.141041505163548
Free cash flow (dilution-adjusted): -9818517
Buyback yield (%): 0
Retained earnings: -41010063
Capitalized R&D asset: 4452768.45
ROCI (R&D-adjusted, %): -98.2527747993436
Rule of 40 score: 0
Financial ratios for TFSL — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 12.93
Shares outstanding: 280432141
Market cap (USD): 3625987583.13
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TFSL — annual report dated 2022-09-30
Total revenue: 291200000
Net income: 74565000
Capital expenditures: 2311000
Operating cash flow: 38929000
Depreciation & amortization: 27035000
Net tangible assets: 1836396000
Owner earnings: 99289000
Return on net tangible assets (%): 5.406731445723036
Buffett classification: The Gruesome
Stock price: 9.47
P/E ratio: 35.61580332957822
Shares outstanding: 280432141
Book value: 1844339000
P/B ratio: 1.4399155335705638
Market cap (USD): 2655692375.27
Debt to equity: 2.615101670571408
Effective tax rate (%): 18.99863123818628
COGS to revenue (%): 0
SG&A to revenue (%): 48.06421703296703
Free cash flow (dilution-adjusted): 25220000
Buyback yield (%): 0.23684972169867777
Retained earnings: 870047000
Receivables turnover: 7.233704292527822
Capitalized R&D asset: 0
FCF margin (%): 8.660714285714285
Rule of 40 score: 8.660714285714285
Financial ratios for TFSL — annual report dated 2023-09-30
Total revenue: 304996000
Net income: 75250000
Capital expenditures: 5101000
Operating cash flow: 90722000
Depreciation & amortization: 18115000
Net tangible assets: 1919961000
Owner earnings: 88264000
Return on net tangible assets (%): 4.597176713485326
Buffett classification: The Gruesome
Stock price: 9.38
P/E ratio: 34.95619245953488
Shares outstanding: 280432141
Book value: 1927361000
P/B ratio: 1.3647954288688005
Market cap (USD): 2630453482.5800004
Debt to equity: 2.7516630252454
Effective tax rate (%): 19.404072102563006
COGS to revenue (%): 0
SG&A to revenue (%): 49.680979422680956
Free cash flow (dilution-adjusted): 75621000
Buyback yield (%): 0.22726119429934416
Retained earnings: 886984000
Receivables turnover: 5.657503246150992
Capitalized R&D asset: 0
FCF margin (%): 24.794095660270955
Revenue growth (%): 4.737637362637362
Rule of 40 score: 29.531733022908316
Financial ratios for TFSL — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.15
Shares outstanding: 280432141
Market cap (USD): 3126818372.15
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TFSL — annual report dated 2024-09-30
Total revenue: 303160000
Net income: 79588000
Capital expenditures: 3064000
Operating cash flow: 88600000
Depreciation & amortization: 19034000
Net tangible assets: 1854997000
Owner earnings: 95558000
Return on net tangible assets (%): 5.151382994150395
Buffett classification: The Gruesome
Stock price: 11.15
P/E ratio: 39.28756058890788
Shares outstanding: 280432141
Book value: 1862624000
P/B ratio: 1.6787168919492073
Market cap (USD): 3126818372.15
Debt to equity: 2.588606181387118
Effective tax rate (%): 20.66033315721791
COGS to revenue (%): 0
SG&A to revenue (%): 46.86766064124554
Free cash flow (dilution-adjusted): 76033000
Buyback yield (%): 0.06156417709277978
Retained earnings: 915489000
Receivables turnover: 5.103875551365366
Capitalized R&D asset: 0
FCF margin (%): 25.080155693363242
Revenue growth (%): -0.6019751078702671
Rule of 40 score: 24.478180585492975
Financial ratios for TFSL — quarterly report dated 2025-03-31
Total revenue: 79117000
Net income: 21021000
Capital expenditures: 6947000
Operating cash flow: 21225000
Depreciation & amortization: 5554000
Net tangible assets: 1888824000
Owner earnings: 19628000
Return on net tangible assets (%): 1.0391651101426072
Buffett classification: The Gruesome
Stock price: 11.21
P/E ratio: 37.38694996206175
Shares outstanding: 280432141
Book value: 1896657000
P/B ratio: 1.6574658995327043
Market cap (USD): 3143644300.61
Debt to equity: 2.4330050188305004
Effective tax rate (%): 20.76218477892118
COGS to revenue (%): 0
SG&A to revenue (%): 45.465576298393515
Free cash flow (dilution-adjusted): 11933000
Buyback yield (%): 0
Retained earnings: 929195000
Receivables turnover: 1.3629112833763997
Capitalized R&D asset: 0
FCF margin (%): 15.082725583629308
Rule of 40 score: 15.082725583629308
Financial ratios for TFSL — quarterly report dated 2025-06-30
Total revenue: 82042000
Net income: 21513000
Capital expenditures: 1726000
Operating cash flow: 26752000
Depreciation & amortization: 5947000
Net tangible assets: 1880235000
Owner earnings: 25734000
Return on net tangible assets (%): 1.3686587048959304
Buffett classification: The Gruesome
Stock price: 11.97
P/E ratio: 39.00865439234416
Shares outstanding: 280432141
Book value: 1888006000
P/B ratio: 1.7779460064057002
Market cap (USD): 3356772727.77
Debt to equity: 2.6023381281627285
Effective tax rate (%): 21.36199144643053
COGS to revenue (%): 0
SG&A to revenue (%): 45.0744740498769
Free cash flow (dilution-adjusted): 22683000
Buyback yield (%): 0.022164145753598888
Retained earnings: 935742000
Receivables turnover: 1.3575470761491875
Capitalized R&D asset: 0
FCF margin (%): 27.648033933838768
Revenue growth (%): 3.697056258452671
Rule of 40 score: 31.34509019229144
Financial ratios for TFSL — quarterly report dated 2025-09-30
Total revenue: 85484000
Net income: 25999000
Capital expenditures: 2143000
Operating cash flow: -11103000
Depreciation & amortization: 6238000
Net tangible assets: 1885375000
Owner earnings: 30094000
Return on net tangible assets (%): 1.5961811310747198
Buffett classification: The Gruesome
Stock price: 12.44
P/E ratio: 50.903591467468225
Shares outstanding: 280432141
Book value: 1893924000
P/B ratio: 1.8419830120110416
Market cap (USD): 3488575834.04
Debt to equity: 2.587509847280039
Effective tax rate (%): 19.852646505749252
COGS to revenue (%): 0
SG&A to revenue (%): 41.53291844087782
Free cash flow (dilution-adjusted): -15855000
Buyback yield (%): 0.0706878714212788
Retained earnings: 946776000
Receivables turnover: 1.3665851358048375
Capitalized R&D asset: 0
FCF margin (%): -18.547330494595478
Revenue growth (%): 4.195412105994491
Rule of 40 score: -14.351918388600987
Financial ratios for TFSL — annual report dated 2025-09-30
Total revenue: 321474000
Net income: 90959000
Capital expenditures: 11453000
Operating cash flow: 82419000
Depreciation & amortization: 23048000
Net tangible assets: 1885375000
Owner earnings: 102554000
Return on net tangible assets (%): 5.439448385599682
Buffett classification: The Gruesome
Stock price: 12.44
P/E ratio: 38.35327822469464
Shares outstanding: 280432141
Book value: 1893924000
P/B ratio: 1.8419830120110416
Market cap (USD): 3488575834.04
Debt to equity: 2.587509847280039
Effective tax rate (%): 20.708712897179968
COGS to revenue (%): 0
SG&A to revenue (%): 44.264855011602805
Free cash flow (dilution-adjusted): 61320000
Buyback yield (%): 0.11400067503748006
Retained earnings: 946776000
Receivables turnover: 5.139225936405928
Capitalized R&D asset: 0
FCF margin (%): 19.074637451240225
Revenue growth (%): 6.041034437260852
Rule of 40 score: 25.115671888501076
Financial ratios for TFSL — quarterly report dated 2025-12-31
Total revenue: 83728000
Net income: 22274000
Capital expenditures: 1662000
Operating cash flow: 58748000
Depreciation & amortization: 6257000
Net tangible assets: 1892137000
Owner earnings: 26869000
Return on net tangible assets (%): 1.420034595803581
Buffett classification: The Gruesome
Stock price: 12.88
P/E ratio: 39.77629451562104
Shares outstanding: 280432141
Book value: 1900965000
P/B ratio: 1.9000696888580275
Market cap (USD): 3611965976.0800004
Debt to equity: 2.6208220561662103
Effective tax rate (%): 21.840129131868903
COGS to revenue (%): 0
SG&A to revenue (%): 47.74269061723677
Free cash flow (dilution-adjusted): 54432000
Buyback yield (%): 0.08272503173584211
Retained earnings: 954158000
Receivables turnover: 1.3886391906459905
Capitalized R&D asset: 0
FCF margin (%): 65.01051022358112
Revenue growth (%): -2.054185578587806
Rule of 40 score: 62.956324644993316
Financial ratios for ULTRACEMCO.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 85.12870895423976
Shares outstanding: 294169635
Market cap (USD): 25042281241.08994
Buyback yield (%): 0
Retained earnings: 1062077014.3742583
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ULTRACEMCO.NS — annual report dated 2023-03-31
Total revenue: 7592886723.507917
Gross profit: 6030493300.852619
Operating income: 922917174.177832
Net income: 617953714.9817296
Capital expenditures: 743676004.8721073
Operating cash flow: 1104568818.5140073
Depreciation & amortization: 351764920.8282582
Net tangible assets: 5801442143.727162
Owner earnings: 226042630.93788052
Return on net tangible assets (%): 3.896317938502415
Capex to operating income (%): 80.57884560817722
Buffett classification: The Gruesome
Stock price: 91.29390986601706
P/E ratio: 43.459397511354325
Shares outstanding: 294169635
Book value: 6623650426.309379
P/B ratio: 4.05454612102362
Market cap (USD): 26855896143.009136
Debt to equity: 0.20334140183820687
Current ratio: 0.885246069549104
Quick ratio: 0.603072577895244
Effective tax rate (%): 31.59076352604078
Interest coverage ratio: 9.944418925126321
COGS to revenue (%): 20.577067452067453
SG&A to revenue (%): 24.83106503939837
Free cash flow (dilution-adjusted): 345045066.9914738
Buyback yield (%): 0.051944127379160925
Retained earnings: 1101863580.9987822
Inventory turnover: 1.940045342968588
Receivables turnover: 16.120320039720507
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.150218592639826
FCF margin (%): 4.544319960986627
Rule of 40 score: 4.544319960986627
Financial ratios for ULTRACEMCO.NS — annual report dated 2024-03-31
Total revenue: 8371451013.310948
Gross profit: 6534044849.502338
Operating income: 1159406403.645521
Net income: 840028780.429308
Capital expenditures: 1065361554.1431826
Operating cash flow: 1306816165.0077946
Depreciation & amortization: 377179517.92780906
Net tangible assets: 6414949034.656433
Owner earnings: 151846744.21393454
Return on net tangible assets (%): 2.367076392869067
Capex to operating income (%): 91.88853458057217
Buffett classification: The Gruesome
Stock price: 115.53059021113243
P/E ratio: 40.45765138710439
Shares outstanding: 294169635
Book value: 7229094615.661349
P/B ratio: 4.701223785357007
Market cap (USD): 33985591553.7434
Debt to equity: 0.18915565838832638
Current ratio: 0.8607152467334375
Quick ratio: 0.5511280771992525
Effective tax rate (%): 25.665501336203146
Interest coverage ratio: 10.073443914230344
COGS to revenue (%): 21.94847895409123
SG&A to revenue (%): 25.28352504307077
Free cash flow (dilution-adjusted): 221716033.0974937
Buyback yield (%): 0.035429755850278036
Retained earnings: 1190142702.9619858
Inventory turnover: 1.8394487703097577
Receivables turnover: 16.317652916206967
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.083635728838011
FCF margin (%): 2.6484779370381095
Revenue growth (%): 10.253864151463778
Rule of 40 score: 12.902342088501888
Financial ratios for ULTRACEMCO.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 5822001911.132346
Buffett classification: The Gruesome
Stock price: 140.0819397993311
Shares outstanding: 294169635
Book value: 7497588389.870999
P/B ratio: 5.496147688839746
Market cap (USD): 41207853100.861206
Debt to equity: 0.2702549203191789
Current ratio: 0.8379062698003752
Quick ratio: 0.5199281366347842
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ULTRACEMCO.NS — quarterly report dated 2024-12-31
Total revenue: 2072366243.1518824
Gross profit: 1698910129.385709
Operating income: 221698333.13906047
Net income: 158927613.94101876
Capital expenditures: 0
Depreciation & amortization: 115722112.13428138
Owner earnings: 274649726.07530016
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 132.35085674321016
P/E ratio: 61.2442392083865
Shares outstanding: 294169635
Market cap (USD): 38933603220.08742
Effective tax rate (%): 19.38365843419442
Interest coverage ratio: 4.164094143404488
COGS to revenue (%): 18.020758396362417
SG&A to revenue (%): 22.701437608661536
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0